annual CAPEX:
$1.25B+$39.00M(+3.23%)Summary
- As of today (April 18, 2025), BMY annual capital expenditures is $1.25 billion, with the most recent change of +$39.00 million (+3.23%) on December 1, 2024.
- During the last 3 years, BMY annual CAPEX has risen by +$275.00 million (+28.26%).
- BMY annual CAPEX is now at all-time high.
Performance
BMY CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$378.00M+$54.00M(+16.67%)Summary
- As of today (April 18, 2025), BMY quarterly capital expenditures is $378.00 million, with the most recent change of +$54.00 million (+16.67%) on December 1, 2024.
- Over the past year, BMY quarterly CAPEX has increased by +$48.00 million (+14.55%).
- BMY quarterly CAPEX is now -19.23% below its all-time high of $468.00 million, reached on December 31, 2002.
Performance
BMY quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$1.25B+$48.00M(+4.00%)Summary
- As of today (April 18, 2025), BMY TTM capital expenditures is $1.25 billion, with the most recent change of +$48.00 million (+4.00%) on December 1, 2024.
- Over the past year, BMY TTM CAPEX has increased by +$39.00 million (+3.23%).
- BMY TTM CAPEX is now -1.27% below its all-time high of $1.26 billion, reached on March 31, 2017.
Performance
BMY TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BMY CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +3.2% | +14.6% | +3.2% |
3 y3 years | +28.3% | +14.6% | +3.2% |
5 y5 years | +49.3% | +14.6% | +3.2% |
BMY CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +28.3% | at high | +53.0% | at high | +18.5% |
5 y | 5-year | at high | +65.7% | at high | +188.6% | at high | +73.1% |
alltime | all time | at high | +240.1% | -19.2% | +410.8% | -1.3% | +985.2% |
Bristol-Myers Squibb CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $1.25B(+3.2%) | $378.00M(+16.7%) | $1.25B(+4.0%) |
Sep 2024 | - | $324.00M(+23.7%) | $1.20B(-1.5%) |
Jun 2024 | - | $262.00M(-7.7%) | $1.22B(+0.2%) |
Mar 2024 | - | $284.00M(-13.9%) | $1.22B(+0.5%) |
Dec 2023 | $1.21B(+8.1%) | $330.00M(-3.5%) | $1.21B(-1.3%) |
Sep 2023 | - | $342.00M(+32.0%) | $1.23B(+8.4%) |
Jun 2023 | - | $259.00M(-6.8%) | $1.13B(-1.1%) |
Mar 2023 | - | $278.00M(-19.7%) | $1.14B(+2.2%) |
Dec 2022 | $1.12B(+14.9%) | $346.00M(+40.1%) | $1.12B(+2.4%) |
Sep 2022 | - | $247.00M(-9.2%) | $1.09B(-2.1%) |
Jun 2022 | - | $272.00M(+7.5%) | $1.11B(+5.9%) |
Mar 2022 | - | $253.00M(-20.9%) | $1.05B(+8.2%) |
Dec 2021 | $973.00M(+29.2%) | $320.00M(+18.5%) | $973.00M(+4.0%) |
Sep 2021 | - | $270.00M(+28.6%) | $936.00M(+14.3%) |
Jun 2021 | - | $210.00M(+21.4%) | $819.00M(+10.7%) |
Mar 2021 | - | $173.00M(-38.9%) | $740.00M(-1.7%) |
Dec 2020 | $753.00M(-9.9%) | $283.00M(+85.0%) | $753.00M(+4.4%) |
Sep 2020 | - | $153.00M(+16.8%) | $721.00M(-4.9%) |
Jun 2020 | - | $131.00M(-29.6%) | $758.00M(-7.3%) |
Mar 2020 | - | $186.00M(-25.9%) | $818.00M(-2.2%) |
Dec 2019 | $836.00M(-12.1%) | $251.00M(+32.1%) | $836.00M(-4.5%) |
Sep 2019 | - | $190.00M(-0.5%) | $875.00M(-3.7%) |
Jun 2019 | - | $191.00M(-6.4%) | $909.00M(-0.8%) |
Mar 2019 | - | $204.00M(-29.7%) | $916.00M(-3.7%) |
Dec 2018 | $951.00M(-9.9%) | $290.00M(+29.5%) | $951.00M(+3.9%) |
Sep 2018 | - | $224.00M(+13.1%) | $915.00M(-4.0%) |
Jun 2018 | - | $198.00M(-17.2%) | $953.00M(-5.0%) |
Mar 2018 | - | $239.00M(-5.9%) | $1.00B(-4.9%) |
Dec 2017 | $1.05B(-13.2%) | $254.00M(-3.1%) | $1.05B(-10.0%) |
Sep 2017 | - | $262.00M(+5.6%) | $1.17B(-6.3%) |
Jun 2017 | - | $248.00M(-14.8%) | $1.25B(-1.0%) |
Mar 2017 | - | $291.00M(-21.6%) | $1.26B(+4.0%) |
Dec 2016 | $1.22B(+48.2%) | $371.00M(+8.8%) | $1.22B(+7.6%) |
Sep 2016 | - | $341.00M(+30.7%) | $1.13B(+10.5%) |
Jun 2016 | - | $261.00M(+7.9%) | $1.02B(+10.4%) |
Mar 2016 | - | $242.00M(-15.1%) | $926.00M(+12.9%) |
Dec 2015 | $820.00M(+55.9%) | $285.00M(+21.8%) | $820.00M(+12.9%) |
Sep 2015 | - | $234.00M(+41.8%) | $726.00M(+21.2%) |
Jun 2015 | - | $165.00M(+21.3%) | $599.00M(+10.1%) |
Mar 2015 | - | $136.00M(-28.8%) | $544.00M(+3.4%) |
Dec 2014 | $526.00M(-2.0%) | $191.00M(+78.5%) | $526.00M(-1.7%) |
Sep 2014 | - | $107.00M(-2.7%) | $535.00M(-3.1%) |
Jun 2014 | - | $110.00M(-6.8%) | $552.00M(+2.2%) |
Mar 2014 | - | $118.00M(-41.0%) | $540.00M(+0.6%) |
Dec 2013 | $537.00M(-2.0%) | $200.00M(+61.3%) | $537.00M(+4.9%) |
Sep 2013 | - | $124.00M(+26.5%) | $512.00M(-2.5%) |
Jun 2013 | - | $98.00M(-14.8%) | $525.00M(-2.8%) |
Mar 2013 | - | $115.00M(-34.3%) | $540.00M(-1.5%) |
Dec 2012 | $548.00M(+49.3%) | $175.00M(+27.7%) | $548.00M(+8.1%) |
Sep 2012 | - | $137.00M(+21.2%) | $507.00M(+11.7%) |
Jun 2012 | - | $113.00M(-8.1%) | $454.00M(+9.4%) |
Mar 2012 | - | $123.00M(-8.2%) | $415.00M(+13.1%) |
Dec 2011 | $367.00M(-13.4%) | $134.00M(+59.5%) | $367.00M(+2.5%) |
Sep 2011 | - | $84.00M(+13.5%) | $358.00M(-1.4%) |
Jun 2011 | - | $74.00M(-1.3%) | $363.00M(-1.9%) |
Mar 2011 | - | $75.00M(-40.0%) | $370.00M(-12.7%) |
Dec 2010 | $424.00M(-41.9%) | $125.00M(+40.4%) | $424.00M(-14.3%) |
Sep 2010 | - | $89.00M(+9.9%) | $495.00M(-13.9%) |
Jun 2010 | - | $81.00M(-37.2%) | $575.00M(-12.6%) |
Mar 2010 | - | $129.00M(-34.2%) | $658.00M(-9.9%) |
Dec 2009 | $730.00M(-22.4%) | $196.00M(+16.0%) | $730.00M(-10.9%) |
Sep 2009 | - | $169.00M(+3.0%) | $819.00M(-3.2%) |
Jun 2009 | - | $164.00M(-18.4%) | $846.00M(-5.2%) |
Mar 2009 | - | $201.00M(-29.5%) | $892.00M(-5.2%) |
Dec 2008 | $941.00M(+11.6%) | $285.00M(+45.4%) | $941.00M(+3.9%) |
Sep 2008 | - | $196.00M(-6.7%) | $906.00M(+1.2%) |
Jun 2008 | - | $210.00M(-16.0%) | $895.00M(+0.4%) |
Mar 2008 | - | $250.00M(0.0%) | $891.00M(+5.7%) |
Dec 2007 | $843.00M | $250.00M(+35.1%) | $843.00M(+2.9%) |
Sep 2007 | - | $185.00M(-10.2%) | $819.00M(-1.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2007 | - | $206.00M(+2.0%) | $834.00M(+5.2%) |
Mar 2007 | - | $202.00M(-10.6%) | $793.00M(0.0%) |
Dec 2006 | $793.00M(+3.3%) | $226.00M(+13.0%) | $793.00M(+3.0%) |
Sep 2006 | - | $200.00M(+21.2%) | $770.00M(+1.9%) |
Jun 2006 | - | $165.00M(-18.3%) | $756.00M(-4.2%) |
Mar 2006 | - | $202.00M(-0.5%) | $789.00M(+2.7%) |
Dec 2005 | $768.00M(-5.1%) | $203.00M(+9.1%) | $768.00M(0.0%) |
Sep 2005 | - | $186.00M(-6.1%) | $768.00M(-13.2%) |
Jun 2005 | - | $198.00M(+9.4%) | $885.00M(+7.0%) |
Mar 2005 | - | $181.00M(-10.8%) | $827.00M(+2.2%) |
Dec 2004 | $809.00M(-18.3%) | $203.00M(-33.0%) | $809.00M(-13.5%) |
Sep 2004 | - | $303.00M(+116.4%) | $935.00M(+6.4%) |
Jun 2004 | - | $140.00M(-14.1%) | $879.00M(-6.5%) |
Mar 2004 | - | $163.00M(-50.5%) | $940.00M(-5.1%) |
Dec 2003 | $990.00M(-16.2%) | $329.00M(+33.2%) | $990.00M(-12.3%) |
Sep 2003 | - | $247.00M(+22.9%) | $1.13B(+0.9%) |
Jun 2003 | - | $201.00M(-5.6%) | $1.12B(-5.5%) |
Mar 2003 | - | $213.00M(-54.5%) | $1.18B(+0.2%) |
Dec 2002 | $1.18B(+15.5%) | $468.00M(+97.5%) | $1.18B(+12.6%) |
Sep 2002 | - | $237.00M(-10.9%) | $1.05B(-3.6%) |
Jun 2002 | - | $266.00M(+26.1%) | $1.09B(+2.8%) |
Mar 2002 | - | $211.00M(-37.2%) | $1.06B(+3.5%) |
Dec 2001 | $1.02B(+73.7%) | $336.00M(+21.7%) | $1.02B(+8.3%) |
Sep 2001 | - | $276.00M(+16.9%) | $945.00M(+17.0%) |
Jun 2001 | - | $236.00M(+34.9%) | $808.00M(+20.1%) |
Mar 2001 | - | $175.00M(-32.2%) | $673.00M(+14.3%) |
Dec 2000 | $589.00M(-16.9%) | $258.00M(+85.6%) | $589.00M(+0.7%) |
Sep 2000 | - | $139.00M(+37.6%) | $585.00M(-2.8%) |
Jun 2000 | - | $101.00M(+11.0%) | $602.00M(-11.2%) |
Mar 2000 | - | $91.00M(-64.2%) | $678.00M(-4.4%) |
Dec 1999 | $709.00M(-10.0%) | $254.00M(+62.8%) | $709.00M(+0.4%) |
Sep 1999 | - | $156.00M(-11.9%) | $706.00M(-2.2%) |
Jun 1999 | - | $177.00M(+45.1%) | $722.00M(-4.5%) |
Mar 1999 | - | $122.00M(-51.4%) | $756.00M(-4.1%) |
Dec 1998 | $788.00M(+2.7%) | $251.00M(+45.9%) | $788.00M(-9.0%) |
Sep 1998 | - | $172.00M(-18.5%) | $866.00M(+0.3%) |
Jun 1998 | - | $211.00M(+37.0%) | $863.00M(+7.9%) |
Mar 1998 | - | $154.00M(-53.2%) | $800.00M(+4.3%) |
Dec 1997 | $767.00M(+27.6%) | $329.00M(+94.7%) | $767.00M(+17.8%) |
Sep 1997 | - | $169.00M(+14.2%) | $651.00M(+5.0%) |
Jun 1997 | - | $148.00M(+22.3%) | $620.00M(+2.1%) |
Mar 1997 | - | $121.00M(-43.2%) | $607.00M(+1.0%) |
Dec 1996 | $601.00M(+17.2%) | $213.00M(+54.3%) | $601.00M(+5.6%) |
Sep 1996 | - | $138.00M(+2.2%) | $569.00M(+2.9%) |
Jun 1996 | - | $135.00M(+17.4%) | $553.00M(+2.8%) |
Mar 1996 | - | $115.00M(-36.5%) | $538.00M(+4.9%) |
Dec 1995 | $513.00M(-10.5%) | $181.00M(+48.4%) | $513.00M(-2.1%) |
Sep 1995 | - | $122.00M(+1.7%) | $524.00M(-3.7%) |
Jun 1995 | - | $120.00M(+33.3%) | $544.00M(-2.2%) |
Mar 1995 | - | $90.00M(-53.1%) | $556.00M(-3.0%) |
Dec 1994 | $573.00M(+0.5%) | $192.00M(+35.2%) | $573.00M(-3.5%) |
Sep 1994 | - | $142.00M(+7.6%) | $594.00M(+2.2%) |
Jun 1994 | - | $132.00M(+23.4%) | $581.00M(+1.6%) |
Mar 1994 | - | $107.00M(-49.8%) | $572.00M(+0.4%) |
Dec 1993 | $570.00M(-11.9%) | $213.00M(+65.1%) | $570.00M(+5.0%) |
Sep 1993 | - | $129.00M(+4.9%) | $543.00M(-5.7%) |
Jun 1993 | - | $123.00M(+17.1%) | $576.00M(-8.6%) |
Mar 1993 | - | $105.00M(-43.5%) | $630.00M(-2.6%) |
Dec 1992 | $647.00M(+3.0%) | $186.00M(+14.8%) | $647.00M(-6.5%) |
Sep 1992 | - | $162.00M(-8.5%) | $692.00M(+2.8%) |
Jun 1992 | - | $177.00M(+45.1%) | $673.00M(+4.7%) |
Mar 1992 | - | $122.00M(-47.2%) | $643.00M(+2.4%) |
Dec 1991 | $628.00M(+22.4%) | $231.00M(+61.5%) | $628.00M(+11.3%) |
Sep 1991 | - | $143.00M(-2.7%) | $564.00M(+6.8%) |
Jun 1991 | - | $147.00M(+37.4%) | $528.00M(+4.6%) |
Mar 1991 | - | $107.00M(-35.9%) | $505.00M(-1.6%) |
Dec 1990 | $513.00M(-7.6%) | $167.00M(+56.1%) | $513.00M(+48.3%) |
Sep 1990 | - | $107.00M(-13.7%) | $346.00M(+44.8%) |
Jun 1990 | - | $124.00M(+7.8%) | $239.00M(+107.8%) |
Mar 1990 | - | $115.00M | $115.00M |
Dec 1989 | $555.00M | - | - |
FAQ
- What is Bristol-Myers Squibb annual capital expenditures?
- What is the all time high annual CAPEX for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual CAPEX year-on-year change?
- What is Bristol-Myers Squibb quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly CAPEX year-on-year change?
- What is Bristol-Myers Squibb TTM capital expenditures?
- What is the all time high TTM CAPEX for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM CAPEX year-on-year change?
What is Bristol-Myers Squibb annual capital expenditures?
The current annual CAPEX of BMY is $1.25B
What is the all time high annual CAPEX for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual capital expenditures is $1.25B
What is Bristol-Myers Squibb annual CAPEX year-on-year change?
Over the past year, BMY annual capital expenditures has changed by +$39.00M (+3.23%)
What is Bristol-Myers Squibb quarterly capital expenditures?
The current quarterly CAPEX of BMY is $378.00M
What is the all time high quarterly CAPEX for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly capital expenditures is $468.00M
What is Bristol-Myers Squibb quarterly CAPEX year-on-year change?
Over the past year, BMY quarterly capital expenditures has changed by +$48.00M (+14.55%)
What is Bristol-Myers Squibb TTM capital expenditures?
The current TTM CAPEX of BMY is $1.25B
What is the all time high TTM CAPEX for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM capital expenditures is $1.26B
What is Bristol-Myers Squibb TTM CAPEX year-on-year change?
Over the past year, BMY TTM capital expenditures has changed by +$39.00M (+3.23%)